IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
2.770
+0.110 (4.14%)
Nov 20, 2024, 4:00 PM EST - Market closed

IM Cannabis Revenue

IM Cannabis had revenue of 13.88M CAD in the quarter ending September 30, 2024, with 12.23% growth. This brings the company's revenue in the last twelve months to 51.39M, down -2.23% year-over-year. In the year 2023, IM Cannabis had annual revenue of 48.80M, down -10.18%.

Revenue (ttm)
51.39M CAD
Revenue Growth
-2.23%
P/S Ratio
n/a
Revenue / Employee
540,989 CAD
Employees
95
Market Cap
7.96M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202348.80M-5.53M-10.18%
Dec 31, 202254.34M20.28M59.56%
Dec 31, 202134.05M18.16M114.30%
Dec 31, 202015.89M6.82M75.12%
Dec 31, 20199.07M3.88M74.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ATI Physical Therapy 728.11M
XWELL 33.83M
RedHill Biopharma 3.71M
Onconetix 1.46M
Syros Pharmaceuticals 386.00K
Soligenix 364.18K
Virax Biolabs Group 156.42K
Revenue Rankings